Modulation of LINE-1 and Alu/SVA Retrotransposition by Aicardi-Goutières Syndrome-Related SAMHD1

Cell Reports

Volumn 4, Issue 6, 2013, Pages 1108-1115

  Zhao, Ke ^a   Du, Juan ^a   Han, Xue ^b,c   Goodier, John L ^d   Li, Peng ^a   Zhou, Xiaohong ^b,c   Wei, Wei ^a   Evans, Sean L ^c   Li, Linzhang ^a   Zhang, Wenyan ^a   Cheung, Ling E ^d   Wang, Guanjun ^a   Kazazian, Haig H ^d   Yu, Xiao Fang ^a,b,c  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LONG INTERSPERSED ELEMENTS 1; RIBONUCLEOPROTEIN; SAMHD1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AICARDI GOUTIERES SYNDROME; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROPOSON; REVERSE TRANSCRIPTION; VIRUS INFECTIVITY;

MAMMALIA;

ALU ELEMENTS; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; HEK293 CELLS; HELA CELLS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MONOMERIC GTP-BINDING PROTEINS; NERVOUS SYSTEM MALFORMATIONS; OPEN READING FRAMES; RIBONUCLEOPROTEINS; SEQUENCE ALIGNMENT; TRANSFECTION;

EID: 84884590112     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.08.019     Document Type: Article

References (48)

1. Ali M., Highet L.J., Lacombe D., Goizet C., King M.D., Tacke U., van der Knaap M.S., Lagae L., Rittey C., Brunner H.G., et al. A second locus for Aicardi-Goutieres syndrome at chromosome 13q14-21. J.Med. Genet. 2006, 43:444-450.
2. An W., Dai L., Niewiadomska A.M., Yetil A., O'Donnell K.A., Han J.S., Boeke J.D. Characterization of a synthetic human LINE-1 retrotransposon ORFeus-Hs. Mob. DNA 2011, 2:2.
3. Aravind L., Koonin E.V. The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem. Sci. 1998, 23:469-472.
4. Baldauf H.M., Pan X., Erikson E., Schmidt S., Daddacha W., Burggraf M., Schenkova K., Ambiel I., Wabnitz G., Gramberg T., et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) Tcells. Nat. Med. 2012, 18:1682-1687.
5. Beck C.R., Garcia-Perez J.L., Badge R.M., Moran J.V. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:187-215.
6. Beck-Engeser G.B., Eilat D., Wabl M. An autoimmune disease prevented by anti-retroviral drugs. Retrovirology 2011, 8:91.
7. Becker K.G., Swergold G.D., Ozato K., Thayer R.E. Binding of the ubiquitous nuclear transcription factor YY1 to a cis regulatory sequence in the human LINE-1 transposable element. Hum. Mol. Genet. 1993, 2:1697-1702.
8. Berger A., Sommer A.F., Zwarg J., Hamdorf M., Welzel K., Esly N., Panitz S., Reuter A., Ramos I., Jatiani A., et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 2011, 7:e1002425.
9. Brouha B., Schustak J., Badge R.M., Lutz-Prigge S., Farley A.H., Moran J.V., Kazazian H.H. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. USA 2003, 100:5280-5285.
10. Cribier A., Descours B., Valadao A.L., Laguette N., Benkirane M. Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1. Cell Reports 2013, 3:1036-1043.
11. Crow M.K. Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease. Autoimmunity 2010, 43:7-16.
12. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., Black D.N., van Bokhoven H., Brunner H.G., Hamel B.C., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat. Genet. 2006, 38:917-920.
13. Dai L., Taylor M.S., O'Donnell K.A., Boeke J.D. Poly(A) binding protein C1 is essential for efficient L1 retrotransposition and affects L1 RNP formation. Mol. Cell. Biol. 2012, 32:4323-4336.
14. Dale R.C., Gornall H., Singh-Grewal D., Alcausin M., Rice G.I., Crow Y.J. Familial Aicardi-Goutières syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures. Am. J. Med. Genet. A. 2010, 152A:938-942.
15. Descours B., Cribier A., Chable-Bessia C., Ayinde D., Rice G., Crow Y., Yatim A., Schwartz O., Laguette N., Benkirane M. SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells. Retrovirology 2012, 9:87.
16. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
17. Goldstone D.C., Ennis-Adeniran V., Hedden J.J., Groom H.C., Rice G.I., Christodoulou E., Walker P.A., Kelly G., Haire L.F., Yap M.W., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 2011, 480:379-382.
18. Goodier J.L., Cheung L.E., Kazazian H.H. MOV10 RNA helicase is a potent inhibitor of retrotransposition in cells. PLoS Genet. 2012, 8:e1002941.
19. Han J.S., Boeke J.D. A highly active synthetic mammalian retrotransposon. Nature 2004, 429:314-318.
20. Hancks D.C., Kazazian H.H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 2012, 22:191-203.
21. Harris C.R., Dewan A., Zupnick A., Normart R., Gabriel A., Prives C., Levine A.J., Hoh J. p53 responsive elements in human retrotransposons. Oncogene 2009, 28:3857-3865.
22. Hrecka K., Hao C., Gierszewska M., Swanson S.K., Kesik-Brodacka M., Srivastava S., Florens L., Washburn M.P., Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661.
23. Kim B., Nguyen L.A., Daddacha W., Hollenbaugh J.A. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J.Biol. Chem. 2012, 287:21570-21574.
24. Kimberland M.L., Divoky V., Prchal J., Schwahn U., Berger W., Kazazian H.H. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum. Mol. Genet. 1999, 8:1557-1560.
25. Kulpa D.A., Moran J.V. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struct. Mol. Biol. 2006, 13:655-660.
26. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Ségéral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657.
27. Lahouassa H., Daddacha W., Hofmann H., Ayinde D., Logue E.C., Dragin L., Bloch N., Maudet C., Bertrand M., Gramberg T., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat. Immunol. 2012, 13:223-228.
28. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921. International Human Genome Sequencing Consortium.
29. Luan D.D., Korman M.H., Jakubczak J.L., Eickbush T.H. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 1993, 72:595-605.
30. Manel N., Littman D.R. Hiding in plain sight: how HIV evades innate immune responses. Cell 2011, 147:271-274.
31. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
32. Mavragani C.P., Crow M.K. Activation of the type I interferon pathway in primary Sjogren's syndrome. J.Autoimmun. 2010, 35:225-231.
33. Moran J.V., Holmes S.E., Naas T.P., DeBerardinis R.J., Boeke J.D., Kazazian H.H. High frequency retrotransposition in cultured mammalian cells. Cell 1996, 87:917-927.
34. Niewiadomska A.M., Tian C., Tan L., Wang T., Sarkis P.T., Yu X.F. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association. J.Virol. 2007, 81:9577-9583.
35. Ostertag E.M., Prak E.T., DeBerardinis R.J., Moran J.V., Kazazian H.H. Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res. 2000, 28:1418-1423.
36. Ostertag E.M., Goodier J.L., Zhang Y., Kazazian H.H. SVA elements are nonautonomous retrotransposons that cause disease in humans. Am. J. Hum. Genet. 2003, 73:1444-1451.
37. Peddigari S., Li P.W., Rabe J.L., Martin S.L. hnRNPL and nucleolin bind LINE-1 RNA and function as host factors to modulate retrotransposition. Nucleic Acids Res. 2013, 41:575-585.
38. Powell R.D., Holland P.J., Hollis T., Perrino F.W. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulateddeoxynucleotide triphosphohydrolase. J.Biol. Chem. 2011, 286:43596-43600.
39. Rice G.I., Bond J., Asipu A., Brunette R.L., Manfield I.W., Carr I.M., Fuller J.C., Jackson R.M., Lamb T., Briggs T.A., et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 2009, 41:829-832.
40. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
41. Tchénio T., Casella J.F., Heidmann T. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 2000, 28:411-415.
42. Thiele H., du Moulin M., Barczyk K., George C., Schwindt W., Nürnberg G., Frosch M., Kurlemann G., Roth J., Nürnberg P., Rutsch F. Cerebral arterial stenoses and stroke: novel features of Aicardi-Goutières syndrome caused by the Arg164X mutation in SAMHD1 are associated with altered cytokine expression. Hum. Mutat. 2010, 31:E1836-E1850.
43. Wang H., Xing J., Grover D., Hedges D.J., Han K., Walker J.A., Batzer M.A. SVA elements: a hominid-specific retroposon family. J.Mol. Biol. 2005, 354:994-1007.
44. Wei W., Guo H., Han X., Liu X., Zhou X., Zhang W., Yu X.F. A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest. Cell. Microbiol. 2012, 14:1745-1756.
45. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L., Kim B., Brojatsch J., Diaz-Griffero F. Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1. Virology 2013, 436:81-90.
46. White T.E., Brandariz-Nuñez A., Valle-Casuso J.C., Amie S., Nguyen L.A., Kim B., Tuzova M., Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013, 13:441-451.
47. Xin B., Jones S., Puffenberger E.G., Hinze C., Bright A., Tan H., Zhou A., Wu G., Vargus-Adams J., Agamanolis D., Wang H. Homozygous mutation in SAMHD1 gene causes cerebral vasculopathy and early onset stroke. Proc. Natl. Acad. Sci. USA 2011, 108:5372-5377.
48. Yang N., Zhang L., Zhang Y., Kazazian H.H. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 2003, 31:4929-4940.